期刊
GLAND SURGERY
卷 10, 期 6, 页码 1865-1873出版社
AME PUBL CO
DOI: 10.21037/gs-21-70
关键词
Pulmonary fibrosis; microcystic lymphatic malformations (microcystic LMs); bleomycin injection; sclerotherapy
类别
资金
- Shanghai Municipal Key Clinical Specialty [shslczdzk00901]
This study evaluated the safety and efficacy of consecutive bleomycin sclerotherapy for large diffuse microcystic LMs. The results showed that this treatment is effective, safe, with good therapeutic effect and low complication rates for microcystic LMs.
Background: Microcystic lymphatic malformations (LMs) are congenital lesions with the diameter of the majority of cysts <1 cm. Bleomycin sclerotherapy has been shown to yield beneficial results for macrocystic LMs. This study aims to evaluate the safety and efficacy of consecutive bleomycin sclerotherapy for large diffuse microcystic LMs. Methods: The location and size of the lesions were detected by ultrasound for the 46 patients included in this study. Bleomycin lavage was performed in larger cysts and intradermal injection for the superficial lesion. The outcome and complications were assessed for its efficacy and safety. Results: The large diffuse microcystic LMs mainly located in the neck, abdominal wall and axilla/lateral chest wall. The average lesion size was 10.6 cm & times; 7.2 cm. The mean number of treatment sessions was 4.5 with 7.3 mg bleomycin for per session averagely. Excellent (69.6%) and moderate (23.9%) responses were obtained. There was no recurrence for the 6 patients (13%) who received a long follow-up. Obvious local swelling, slight intralesional hemorrhage and low-grade fever were the most commonly occurred complications. No lung fibrosis was identified for the patients who received more than 6 sessions. Conclusions: Local lavage combined with intradermal injection of bleomycin is effective and safe for large diffuse microcystic LMs with good therapeutic effect and low complication rates, and can be regarded as the mainstay of therapy for microcystic LMs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据